Publications by authors named "Daniel Mytelka"

Claim this Profile
F
Forecasting clinical trial success using anonymized external expert panels.
Frank S David, R Edward Benson, Mark Gordon, Daniel S Mytelka

Drug Discov Today· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occurrence and Characteristics of Hospitalizations During First-Line Chemotherapy Among Individuals with Metastatic Colorectal Cancer.
Michael J Fisch, Michael Grabner, Daniel S Mytelka, Amit D Raval, Lee Bowman

Cancer Manag Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and survival outcomes for patients receiving second-line treatment for metastatic colorectal cancer in the USA.
Lisa M Hess, Zhanglin Lin Cui, Daniel S Mytelka, Yimei Han, Robert Goodloe

Int J Colorectal Dis· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Care Resource Utilization and Costs among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and France.
Daniel S Mytelka, Saurabh P Nagar, Yulia D'yachkova, Elizabeth M La, James A Kaye

Sarcoma· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Patterns and Survival among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and France.
Saurabh P Nagar, Daniel S Mytelka, Sean D Candrilli, Yulia D'yachkova, Maria Lorenzo

Sarcoma· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set.
Axel Grothey, Takayuki Yoshino, Gyorgy Bodoky, Tudor Ciuleanu, Rocio Garcia-Carbonero, Daniel S Mytelka

ESMO Open· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-diagnosis weight loss as a prognostic factor in non-small cell lung cancer.
Daniel S Mytelka, Li Li, Karin Benoit

J Cachexia Sarcopenia Muscle· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy treatment patterns, costs, and outcomes of patients with gastric cancer in the United States: a retrospective analysis of electronic medical record (EMR) and administrative claims data.
Lisa M Hess, Diane Michael, Daniel S Mytelka, Julie Beyrer, Astra M Liepa

Gastric Cancer· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and outcomes among patients with high-intermediate/high-risk diffuse large B-cell lymphoma in the USA.
Daniel S Mytelka, Li Li, Dana Stafkey-Mailey, Astra M Liepa, Lisa M Hess

Hematology· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the incremental net health benefit of requirements for cardiovascular risk evaluation for diabetes therapies.
Anita J Chawla, Daniel S Mytelka, Stephan D McBride, Dave Nellesen, Benjamin R Elkins

Pharmacoepidemiol Drug Saf· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the utility of existing patient-reported outcome scales in novel patient populations with pancreatic cancer, lung cancer, and myeloproliferative neoplasms using medicare current beneficiary survey data.
Jasmina I Ivanova, Daniel S Mytelka, Mei Sheng Duh, Howard G Birnbaum, Alice Kate Cummings

Patient· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare costs, treatment patterns, and resource utilization among pancreatic cancer patients in a managed care population.
Stacey DaCosta Byfield, Emily Nash Smyth, Daniel Mytelka, Lee Bowman, April Teitelbaum

J Med Econ· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to improve R&D productivity: the pharmaceutical industry's grand challenge.
Steven M Paul, Daniel S Mytelka, Christopher T Dunwiddie, Charles C Persinger, Bernard H Munos

Nat Rev Drug Discov· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis